Filtern
Volltext vorhanden
- ja (9)
Gehört zur Bibliographie
- ja (9)
Dokumenttyp
Schlagworte
- BRAF (2)
- PD-1 (2)
- immunohistochemistry (2)
- melanoma (2)
- B7-H1 Antigen (1)
- CARMO (1)
- COX2 expression (1)
- CTLA-4 Antigen (1)
- Drug Therapy, Combination (1)
- Experimentelle Tumortherapie (1)
- Immune-related adverse event (1)
- Ipilimumab (1)
- Katdiotoxizität (1)
- Merkel cell carcinoma (1)
- Minimal change disease (1)
- NRF2 (1)
- Nivolumab (1)
- PRAME (1)
- Programmed Cell Death 1 Receptor (1)
- Skin Neoplasms (1)
- adjuvant treatment (1)
- avelumab (1)
- cardiotoxicity (1)
- cell rich blue nevus (1)
- checkpoint blocker (1)
- clinical trials (1)
- common blue nevus (1)
- ipilimumab (1)
- lactate dehydrogenase (1)
- melanocytic markers (1)
- melanoma malignancy (1)
- nivolumab (1)
- resistance (1)
- rhabdoid differentiation (1)
- rhabdoid melanoma (1)
- satellitosis (1)
- skin (1)
- targeted therapy (1)
Institut
- Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie (8)
- Institut für diagnostische und interventionelle Neuroradiologie (ehem. Abteilung für Neuroradiologie) (1)
- Medizinische Fakultät (1)
- Medizinische Klinik und Poliklinik II (1)
- Physiologisches Institut (1)
- Rudolf-Virchow-Zentrum (1)
- Theodor-Boveri-Institut für Biowissenschaften (1)
Sonstige beteiligte Institutionen
Blue nevus is a benign melanocytic lesion, typically asymptomatic and of unknown etiology. Several histologic and clinical variants have been distinguished, the most frequent being common blue nevus, cellular blue nevus, and combined blue nevus. Although melanocytic nevi with a satellite lesion are usually suggestive of locally advanced malignant melanoma, very few cases of blue nevi with satellite lesions have been reported. The diagnosis of common or cellular blue nevi is generally straightforward; however, the presence of structures such as irregular edges or satellitosis are highly suggestive for malignancy, and differential diagnoses such as locally advanced malignant melanoma and malignant blue nevus should be considered. Recurrent blue nevi can display atypical features not seen in the primary lesion, such as pleomorphism and mitotic activity. They usually tend to follow a benign course; however, in some cases, recurrence may indicate malignant transformation. We here report the unique case of a 64-year-old woman with a recurrent cellular blue nevus accompanied by satellite lesions. Such a biological behavior resulting in a clinical presentation as a melanoma-like lesion is a rarity in blue nevus and has not been described before.